Why women's desire may change, how stress and menopause fit into the picture, and when a concern is worth discussing with a clinician.
On September 30, 2026, Telemundo published a La Mesa Caliente segment that posed a familiar question about women's changing sexual desire: “mind or hormones?” Its summary described a specialist discussing stress, fatigue and routine alongside age and hormones. Testosterone and the question of when to consult a professional were also included.
The question is useful as a starting point, but it sets up a choice that clinical guidance does not make. Mayo Clinic describes desire as something that can rise and fall across a person's life. It lists physical health and emotional wellbeing alongside relationships, medications and hormonal life stages as possible influences.
For women in midlife, the more useful question is what has changed and whether that change is troubling. A hormone may belong in the discussion without becoming the whole explanation. The distinction matters because understanding a change is not the same as deciding that it needs treatment.
Telemundo's segment was a news discussion, not a study that tested why desire changes. The clinical context here comes from Mayo Clinic's patient information and from reports about testosterone evidence.
Mayo Clinic's material considers women's sexual health across different life circumstances. Its scope includes pregnancy, childbirth and breastfeeding as well as perimenopause and menopause. It also addresses health, mood and relationship context rather than focusing on a single hormone.
Testosterone evidence has a narrower focus. A September 2026 Medscape report described an international panel's evidence assessment concerning postmenopausal women with hypoactive sexual desire disorder, or HSDD. Separately, the International Society for Sexual Medicine summarized trials involving postmenopausal women and several sexual-function outcomes.
These sources have distinct roles. The news segment introduces a question, while clinical guidance offers a way to understand the concern. The trial summaries and expert assessment address treatment in a defined group. Keeping those roles separate helps prevent a broad discussion about desire from turning into a recommendation for every woman.
One of Mayo Clinic's central points is that desire naturally fluctuates. There is no single amount that everyone is supposed to have. A change becomes worth discussing when it causes concern or distress, or affects wellbeing or a relationship. That is a different standard from simply comparing today's interest with an earlier stage of life.
Mayo Clinic includes stress and fatigue among possible influences on desire. It also lists depression or anxiety, body-image concerns and relationship changes. This means that an account of changing desire may need to include emotional wellbeing and everyday circumstances, not just reproductive life stage.
Routine also featured in the Telemundo summary. It belongs among the possibilities mentioned in that discussion, not as a verdict on any particular partnership. The point is to leave room for context without assigning blame.
These categories are not a way to divide women into those with a “physical” problem and those with an “emotional” one. Mayo Clinic's broad list is a reminder that an assessment may consider more than one area. The value lies in asking about relevant influences without deciding on the answer in advance.
Perimenopause and menopause belong in this picture, but so do pain and chronic illness. Mayo Clinic also includes medications and changing life circumstances among possible contributors. For a midlife reader, age is part of the context rather than a complete answer.
Comfort deserves its own attention. Painful sex and persistent vaginal dryness are among the symptoms Mayo Clinic identifies for discussion with a clinician. A description such as “less interested” may be too broad to capture every concern a person wants to raise.
According to Medscape, the international panel found evidence supporting testosterone for postmenopausal women with HSDD and described the therapeutic benefit as modest. The International Society for Sexual Medicine reports that trials in postmenopausal women showed improvements in desire as well as pleasure and satisfaction. Those findings address treatment outcomes in a particular population.
The Telemundo summary does not identify the specialist or supply a transcript. It provides no detailed clinical advice, statistics or specific threshold for seeking care. The discussion therefore supports the topic, not an account of precisely what an expert recommended.
The available summaries of the testosterone evidence do not supply sample sizes or follow-up durations. They also lack enough design detail to assess individual trial methods or calculate an effect size. “Modest benefit” should remain a qualitative description rather than being converted into a percentage or expected personal improvement.
The panel's conclusion is an expert assessment of evidence, not a new experiment performed by the panel. The trials concern postmenopausal women, so the findings should not be generalized to all women or all changes in desire. An improvement reported in trials is not a guarantee for an individual.
These sources also do not establish that a low testosterone result alone diagnoses a desire disorder or explains someone's symptoms. The news segment does not isolate a single cause from overlapping influences. It cannot tell a particular woman how much of her changing desire is related to stress or hormones.
Set beside Mayo Clinic's guidance, the Telemundo discussion reinforces a broad view rather than replacing it. Both descriptions include stress and fatigue among possible influences. Mayo Clinic supplies fuller context by also considering health, medication use and relationship circumstances.
The important point of agreement is that hormones belong in a wider assessment. Menopause is one possible setting for a change in desire. It is not a reason to set aside questions about mood, comfort or daily life.
Reported testosterone benefits fit within that framework. The treatment evidence addresses a specific clinical question after evaluation, whereas the broader guidance starts with the person's experience and circumstances. These strands of information serve different purposes and do not need to compete.
Sexential's closer look at the evidence for testosterone offers related context on this narrower topic. The useful distinction is between evidence about a treatment for a defined group and an explanation for an individual change in desire.
Mayo Clinic's absence of a required desire level also changes the meaning of the news. A difference from the past is not automatically a sign of failure. The person's concern and the effect on wellbeing matter more than treating desire as a standard everyone must meet.
The practical message is not to choose between a mental explanation and a hormonal one. It is to describe the change clearly enough that a qualified professional can consider the relevant context. Mayo Clinic points to concern, distress and effects on a relationship or quality of life as reasons to seek advice.
That conversation can also include pain, persistent vaginal dryness or bleeding after sex. Symptoms beginning after a medication change are another reason Mayo Clinic gives for discussion. These details deserve to be raised rather than folded into a general label of low desire.
An appointment does not have to start with a theory about which hormone is responsible. Mayo Clinic describes an assessment that may draw on several parts of a person's history. Topics it identifies include:
The distinction between a consistent change and a situation-specific change is part of Mayo Clinic's evaluation framework. It gives the clinician more information than a single statement that desire has dropped. The same is true of describing discomfort separately from interest, rather than assuming both have the same explanation.
These topics help organize a conversation rather than establish a diagnosis. Mayo Clinic says an examination or blood testing may be appropriate depending on the concern. A clinician can decide which parts of an assessment are relevant to the person's symptoms and history.
Related reading on separating physical discomfort from changes in desire and recognizing when low desire becomes a concern provides further educational context. The aim is better language for the concern, not an expectation that every change needs the same response.
This broader framing leaves room for confidence without dismissing a troubling experience. A change in desire can be discussed as something with context, rather than as a personal shortcoming. Professional attention and acceptance of natural variation are not opposing choices.
The question on the screen was “mind or hormones?” After looking at the clinical context, the answer begins with a wider conversation: what has changed, what else is happening and what matters to the woman experiencing it. That shifts the focus from finding a single culprit to understanding the person.
Women living with changing desire carry the day-to-day uncertainty; Sexential adds a calm educational perspective. For adults aged 35 to 65, its articles connect sexual wellbeing with health and relationship context, helping readers understand unsettling changes without treating reduced confidence as a personal failure or replacing individual medical care.
Follow Sexential for thoughtful guidance on desire, sexual function, hormones, confidence, relationships and intimacy. Explore new articles and evidence-aware resources for sexual wellbeing across adulthood.
A report on a student survey links attention with men’s sexual satisfaction. Here’s the evidence, its limits and the practical context for midlife.
A new report puts men’s midlife testosterone changes in context, with guidance on assessment, partner conversations and fertility considerations.
The Menopause Society’s 2026 program places lifestyle, sleep and sexual health together. Here is what the agenda and partner research actually report.
Explore practical resources on desire, function, hormones, confidence, intimacy and sexual wellbeing.
Read the Blog
